Daré Bioscience, Inc. (DARE)
0.8176
+0.02
(+2.01%)
USD |
NASDAQ |
Aug 25, 11:21
Daré Bioscience Market Cap : 12.40M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 12.16M |
| August 21, 2026 | 12.44M |
| August 20, 2026 | 12.28M |
| August 19, 2026 | 12.51M |
| August 18, 2026 | 11.65M |
| August 17, 2026 | 12.29M |
| August 14, 2026 | 14.11M |
| August 13, 2026 | 20.78M |
| August 12, 2026 | 21.84M |
| August 11, 2026 | 21.84M |
| August 10, 2026 | 19.80M |
| August 07, 2026 | 20.38M |
| August 06, 2026 | 19.36M |
| August 05, 2026 | 19.51M |
| August 04, 2026 | 19.51M |
| August 03, 2026 | 18.64M |
| July 31, 2026 | 17.76M |
| July 30, 2026 | 18.05M |
| July 29, 2026 | 16.89M |
| July 28, 2026 | 17.25M |
| July 27, 2026 | 19.22M |
| July 24, 2026 | 18.64M |
| July 23, 2026 | 18.34M |
| July 22, 2026 | 17.76M |
| July 21, 2026 | 18.20M |
| Date | Value |
|---|---|
| July 20, 2026 | 19.51M |
| July 17, 2026 | 28.54M |
| July 16, 2026 | 28.25M |
| July 15, 2026 | 30.14M |
| July 14, 2026 | 30.14M |
| July 13, 2026 | 30.43M |
| July 10, 2026 | 29.41M |
| July 09, 2026 | 30.14M |
| July 08, 2026 | 29.56M |
| July 07, 2026 | 29.85M |
| July 06, 2026 | 30.28M |
| July 02, 2026 | 30.43M |
| July 01, 2026 | 30.72M |
| June 30, 2026 | 30.72M |
| June 29, 2026 | 30.58M |
| June 26, 2026 | 30.43M |
| June 25, 2026 | 29.12M |
| June 24, 2026 | 30.28M |
| June 23, 2026 | 30.14M |
| June 22, 2026 | 29.85M |
| June 18, 2026 | 31.59M |
| June 17, 2026 | 30.28M |
| June 16, 2026 | 30.72M |
| June 15, 2026 | 28.83M |
| June 12, 2026 | 29.41M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 2.582B |
| Elite Pharmaceuticals, Inc. | 311.40M |
| Eton Pharmaceuticals, Inc. | 1.781B |
| ANI Pharmaceuticals, Inc. | 1.703B |
| Corcept Therapeutics, Inc. | 13.25B |
Market Cap Related Metrics
| PS Ratio | 8.480 |
| Price | 0.8176 |
| Earnings Yield | -96.09% |